IntegraGen Logo

IntegraGen

ISIN: FR0010908723 | Ticker: ALINT | LEI: 969500CQD8K0BUIGDH55
Sector: Health CareSub-Industry: Biotechnology
Country: France

About IntegraGen

Company Description

IntegraGen is an OncoDNA Group company specializing in the genomics of cancer and genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in genomic services which has been operating sequencing platforms for research institutes of excellence.

IntegraGen's mission is to translate molecular research into clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting-edge genomic services to academic researchers and life sciences companies based on the company's technological expertise and scientific know-how.

Year founded

2000

Served area

Worldwide

Headcount

50

Headquarters

Genopole Campus 1 - Bâtiment 8 5 Rue de Henri Desbruères, 91000 Évry – France

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FR0010908723

LEI

969500CQD8K0BUIGDH55

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.